Defibtech Wins a Technology Innovation Award
Guilford, CT – September 24 – Defibtech announced today that it has received a Technology Innovation Award from the Greater New Haven Chamber of Commerce.
Each year the Chamber presents the Growth and Innovation Awards to members who are outstanding in their fields. Defibtech has been recognized with the 2004 Technology Innovation Award for its outstanding contribution and excellence in biotechnology.
Defibtech has recently been recognized with a variety of international and state awards recognizing the development of the industry-leading Lifeline Automated External Defibrillator (AED). "It is a great honor to add the recognition of our local community to that already received at the state and international levels. I am pleased that the Greater New Haven Chamber of Commerce stands behind our efforts and that our mission is recognized close to home," said Gintaras Vaisnys, Defibtech president and Connecticut native. "Our goal is to produce the best medical devices available, to benefit as many people as possible, and that of course includes people in our local community."
Founded in 1999, Defibtech is headquartered in Guilford, Connecticut and manufactures all of its defibrillators in Connecticut in a state-of-the-art ISO-9001:2003 certified facility. Defibtech's AEDs are sold throughout the USA and are exported to a number of foreign markets in Europe.
Featuring industry-leading biphasic defibrillation technology, the Defibtech AED is the market's most affordable unit, with a single-unit list price of $1,495 in the United States. Easy to use and portable, the Defibtech AED actually "talks" to the user, giving audible step-by-step instructions on how to give lifesaving defibrillation. The AED's bright coloring and award-winning design make it easy to find and operate quickly. Having the industry's longest operational battery life, the Defibtech AED is built to the durability standards of professional emergency personnel.
AEDs dramatically improve the chances of surviving sudden cardiac arrest (SCA), which causes the heart to become arrhythmic and stop pumping blood effectively. The majority of SCA victims receiving timely defibrillation survive; without it, fewer than 5 percent of SCA victims live. AEDs deliver a defibrillating electrical shock that restores the heart's rhythm to normal. More than 400,000 people die from SCA annually.
About Defibtech
Defibtech relentlessly pursues one goal: making the best automatic external defibrillators (AEDs) in the world at affordable prices. Defibtech designs and manufactures the FDA-cleared Lifeline™ and ReviveR™ brand AEDs and related accessories. Defibtech's products are sold through its network of distribution partners in the United States and around the world. Founded in 1999, Defibtech is headquartered in Guilford, Connecticut and manufactures all of its defibrillators in the United States in state-of-the-art ISO 13485:2003 certified facilities. For more information about Defibtech and its products, visit www.defibtech.com or call 1-866-DEFIB-4-U (1-866-333-4248).
Contact
Defibtech, LLC
Greg Slusser
Vice President, Sales & Marketing
866-333-5641
greg@defibtech.com
or Defibtech Sales:
866-333-4248
sales@defibtech.com
|
